Related Experiment Video
Updated: Mar 29, 2026
04:23
Directed Differentiation of Hemogenic Endothelial Cells from Human Pluripotent Stem Cells
Published on: March 31, 2021
2.8K
On signaling pathways: hematopoietic stem cell specification from hemogenic endothelium
1Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, China.
Science China. Life Sciences
|November 28, 2015
Summary
Generating hematopoietic stem cells (HSCs) from pluripotent stem cells (PSCs) is challenging due to undefined intraembryonic signals. This review focuses on conserved signaling pathways controlling HSC specification from hemogenic endothelium.
Area of Science:
- Developmental Biology
- Stem Cell Biology
- Hematopoiesis
Background:
- Hematopoietic stem cells (HSCs) are crucial for lifelong blood cell production.
- Generating functional HSCs from pluripotent stem cells (PSCs) remains a significant challenge.
- Understanding the molecular signals governing HSC specification is critical.
Purpose of the Study:
- To review conserved signaling pathways involved in HSC specification from hemogenic endothelium.
- To bridge the gap between in vivo and in vitro findings on HSC development.
- To highlight key intraembryonic signals essential for HSC generation.
Main Methods:
- Review of in vivo and in vitro studies on HSC specification.
- Focus on conserved signaling pathways controlling hemogenic endothelium development.
- Analysis of molecular events during embryonic HSC generation.
Main Results:
- Identified conserved signaling pathways critical for HSC specification.
- Highlighted the role of hemogenic endothelium as the direct source of HSCs.
- Summarized key intraembryonic signals influencing HSC fate.
Conclusions:
- Conserved signaling pathways are essential for specifying HSCs from hemogenic endothelium.
- Further research into these pathways could overcome challenges in generating functional HSCs.
- This review provides a foundation for future therapeutic strategies in regenerative medicine.
Related Concept Videos
01:01Regulation of Hematopoietic Stem Cells
4.4K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.4K
01:21Hematopoiesis
9.8K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
9.8K
01:19Multipotency of Hematopoietic Stem Cells
4.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
4.1K
01:34Production of Formed Elements
5.6K
Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Most HSCs commit to...
5.6K
01:24Regulation of Angiogenesis and Blood Supply
4.0K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
4.0K
01:28Role of Hematopoietic Growth Factors
4.3K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
4.3K